On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Peter G. Rose

ResearcherPublications, citations & collaboration network

Peter G. Rose is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Peter G. Rose have?

ScholarIQindexed works

Peter G. Rose has 440 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Peter G. Rose have?

ScholarIQcitation count

Peter G. Rose has 18,573 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Peter G. Rose?

ScholarIQh-index

Peter G. Rose has an h-index of 65 in OpenAlex.

What is the i10-index of Peter G. Rose?

ScholarIQi10-index

Peter G. Rose has an i10-index of 211 in OpenAlex.

What is the ORCID of Peter G. Rose?

ScholarIQorcid

The ORCID for Peter G. Rose is on the source record.

What is the OpenAlex record for Peter G. Rose?

ScholarIQopenalex

The OpenAlex for Peter G. Rose is on the source record.

What are the most-cited papers on Peter G. Rose?

ScholarIQmost cited works
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Peter G. Rose, Brian N. Bundy, E. Blake Watkins, J.T. Thigpen, Günther Deppe, Mitchell Maiman, Daniel L. Clarke‐Pearson, Sam J. Insalaco
New England Journal of Medicine. 19992,684 CitationsOPEN ACCESS
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
William E. Winter, G. Larry Maxwell, Chunqiao Tian, Jay W. Carlson, Robert F. Ozols, Peter G. Rose, Maurie Markman, Deborah K. Armstrong, Franco M. Muggia, William P. McGuire
Journal of Clinical Oncology. 2007850 CitationsOPEN ACCESS
Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
William E. Winter, G. Larry Maxwell, Chunqiao Tian, Michael J. Sundborg, G. Scott Rose, Peter G. Rose, Stephen C. Rubin, Franco M. Muggia, William P. McGuire
Journal of Clinical Oncology. 2007405 CitationsOPEN ACCESS
Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.
Peter G. Rose, John A. Blessing, Andrew R. Mayer, H D Homesley
Journal of Clinical Oncology. 1998404 Citations
Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma
Peter G. Rose, Stacy Nerenstone, Mark F. Brady, Daniel L. Clarke‐Pearson, George J. Olt, Stephen C. Rubin, David H. Moore, James M. Small
New England Journal of Medicine. 2004401 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial